Retraction: Immunity to Murine Prostatic Tumors: Continuous Provision of T-Cell Help Prevents CD8 T-Cell Tolerance and Activates Tumor-Infiltrating Dendritic Cells.
出版信息
Cancer Res. 2016 Apr 15;76(8):2490. doi: 10.1158/0008-5472.CAN-16-0505. Epub 2016 Mar 24.
Abstract
摘要
相似文献
1
Retraction: Immunity to Murine Prostatic Tumors: Continuous Provision of T-Cell Help Prevents CD8 T-Cell Tolerance and Activates Tumor-Infiltrating Dendritic Cells.撤稿声明：对小鼠前列腺肿瘤的免疫：持续提供T细胞辅助可防止CD8 T细胞耐受并激活肿瘤浸润树突状细胞。
Cancer Res. 2016 Apr 15;76(8):2490. doi: 10.1158/0008-5472.CAN-16-0505. Epub 2016 Mar 24.
2
Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8+ T-cell density and activity, and enlarges draining lymph nodes.肿瘤内白细胞介素-21 增加抗肿瘤免疫、肿瘤浸润 CD8+T 细胞密度和活性，并增大引流淋巴结。
J Immunother. 2010 Apr;33(3):236-49. doi: 10.1097/CJI.0b013e3181c0c1cb.
3
4
Melanoma-infiltrating dendritic cells induce protective antitumor responses mediated by T cells.黑色素瘤浸润性树突状细胞诱导由T细胞介导的保护性抗肿瘤反应。
Melanoma Res. 2007 Jun;17(3):169-76. doi: 10.1097/CMR.0b013e3281844531.
5
β-catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8⁺ T cells.β-连环蛋白通过抑制 CD8⁺ T 细胞的交叉呈递来介导肿瘤诱导的免疫抑制。
J Leukoc Biol. 2014 Jan;95(1):179-90. doi: 10.1189/jlb.0613330. Epub 2013 Sep 10.
6
Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway.肿瘤浸润性γδ T细胞通过由独特的Toll样受体信号通路控制的机制抑制T细胞和树突状细胞的功能。
Immunity. 2007 Aug;27(2):334-48. doi: 10.1016/j.immuni.2007.05.020. Epub 2007 Jul 26.
7
High DGK-α and disabled MAPK pathways cause dysfunction of human tumor-infiltrating CD8+ T cells that is reversible by pharmacologic intervention.高活性的 DGK-α 和失活的 MAPK 通路导致浸润在肿瘤中的人类 CD8+ T 细胞功能障碍，这种障碍可通过药物干预来逆转。
J Immunol. 2012 Jun 15;188(12):5990-6000. doi: 10.4049/jimmunol.1103028. Epub 2012 May 9.
8
Combinational FLt3 ligand and granulocyte macrophage colony-stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8(+) T-cell cross-priming but is ineffective as a therapy.联合使用Flt3配体和粒细胞巨噬细胞集落刺激因子治疗可促进树突状细胞增强肿瘤浸润及抗肿瘤CD8(+) T细胞的交叉启动，但作为一种治疗方法无效。
Cancer Res. 2006 May 1;66(9):4895-903. doi: 10.1158/0008-5472.CAN-05-2384.
9
High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.在早期大型宫颈癌患者中，上皮内CD8 +肿瘤浸润淋巴细胞数量较多与无淋巴结转移相关。
Cancer Res. 2007 Jan 1;67(1):354-61. doi: 10.1158/0008-5472.CAN-06-3388.
10
Direct CD4 help provision following interaction of memory CD4 and CD8 T cells with distinct antigen-presenting dendritic cells.直接提供 CD4 帮助，以在记忆性 CD4 和 CD8 T 细胞与不同的抗原呈递树突状细胞相互作用后。
J Immunol. 2010 Jul 15;185(2):1028-36. doi: 10.4049/jimmunol.0904209. Epub 2010 Jun 18.
本文引用的文献
1
Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells.对小鼠前列腺肿瘤的免疫：持续提供T细胞辅助可防止CD8 T细胞耐受并激活肿瘤浸润性树突状细胞。
Cancer Res. 2009 Aug 1;69(15):6256-64. doi: 10.1158/0008-5472.CAN-08-4516. Epub 2009 Jul 21.
Zotero 插件